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Introduction
Buccal route is a useful method of administration when 
rapid onset of actions is desired. The ease of usage, patient 
compliance and improved bioavailability are other advan-
tages of this route (1). Tablets and capsules are the most 
popular solid dosage forms.
However, many people face difficulty in swallowing tablets 
and hard gelatin capsules (2). It has been found that this 
problem has been encountered in all groups of patients, 
especially with pediatric and geriatric populations. Thus, 
these conventional dosage forms result in high incidence 
of noncompliance and ineffective therapy with respect to 
swallowing especially in the case of pediatric, geriatric, 
and any mentally retarded persons (3).
However, it offers several advantages with respect to its 
stability, administration without water, accurate dosing, 
easy manufacturing, small packaging size, and handling 
(4). Its ease of administration in the population especially 
for pediatric, geriatric, or any mentally retarded persons 
makes it a very popular dosage form. Due to the presence 
of superdisintegrants, it gets dissolved quickly, resulting 
in rapid absorption of drug which in turn provides rapid 
onset of action (5).
Ondansetron has a high oral bioavailability of 60%. The 
half-life is 3 to 4 hours and the Tmax is 1.5 hours for the 
conventional tablet and slightly longer for the oral drug 
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Introduction: Difficulty in swallowing is common among all age groups, especially elderly and 
pediatrics. Orally disintegrating tablets may constitute an innovative dosage form that overcome 
the problem of swallowing and provide a quick onset of action. This study was aimed to formulate 
and evaluate an orally disintegrating tablet (ODT) containing ondansetron while using semi-
synthetic and natural superdisintegrants.
Methods: Orodispersible tablets were prepared by direct compression using natural superdisintegrant 
(Karaya gum) and semi-synthetic superdisintegrant (croscarmellose). The prepared tablets were 
evaluated for hardness, friability, thickness, drug content uniformity, water absorption and wetting 
time. A 32 factorial design was used to investigate the effect of independent variables (amount 
of croscarmellose and Karaya gum) on dependent variables (disintegration time, friability and 
Q5 [cumulative amount of drug release after 5 minutes]). A counter plot was also presented to 
graphically represent the effect of independent variable on the disintegration time, friability and Q5. 
The check point batch was also prepared to prove the validity of the evolved mathematical model. 
The systematic formulation approach helped in understanding the effect of formulation processing 
variable.
Results: According to the results of optimized batches, the best concentrations of superdisintegrant 
were as follows: 7.88 mg Karaya gum and 7.78 mg croscarmellose gave rapid disintegration in 31 
seconds which showed 99% drug release within 5 minutes.
Conclusion: Karaya gum, a natural superdisintegrant, gives a rapid disintegration and high release 
when used with synthetic superdisintegrant in formulation of ODT.
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therapy (ODT). In cancer chemotherapy, drug induced 
nausea and vomiting may occur so regularly that anticipa-
tory vomiting occurs when patients return for treatment 
before the chemotherapeutic agent is given. If not con-
trolled, the discomfort associate with drug induced em-
esis may cause a patient to refuse further chemotherapy. 
In this condition ondansetron hydrochloride is a drug of 
choice  (6,7).
In market ondansetron is available in freeze dried dosage 
form which gives rapid disintegration. Main disadvantage 
of this method is very costly method, process is not fea-
sible and product is highly sensitive to moisture. Freeze 
drying is cumbersome and it yields a fragile and hygro-
scopic product (8).
In this study natural superdisintegrants were utilized. 
Natural superdisintegrants are safer, more biodegradable, 
better compressible, easier to preparation and cheaper and 
these advantages can boost the production of ODTs (9). 
In the present study, the fast disintegrating tablets were 
prepared by the method of direct compression using vari-
ous pharmaceutical excipients. The excipients used were 
avicel PH102, croscarmellose, Karaya gum, mannitol, as-
partame, aerosil and magnesium stearate.
Materials and Methods
Ondansetron hydrochloride was a gift from Amin Phar-
maceutical Company (Iran). Aerosil and aspartame were 
obtained as gift from Isfahan University of Medical Sci-
ence Lab and other ingredients were bought from mar-
ket. Croscarmellose (Macleods Pharmaceuticals, India), 
Karaya gum (Nutriroma, India), aspartame (Fluka, Swit-
zerland), Avicel PH102, Magnesium stearate, Mannitol 
(Merck, Germany).
Preparation of orally disintegrating tablets
Orally disintegrating tablet (ODT) of ondansetron was 
prepared by direct compression method. All the ingredi-
ents were passed through 60 mesh sieve separately. The 
ondansetron, croscarmellose, Karaya gum, avicel PH102, 
mannitol and aspartame were mixed up using a mortar 
and pestle. The blends were lubricated with 1% magne-
sium stearate and 1% aerosil. The blends ready for com-
pression were converted into tablets. Tablets were com-
pressed at 3 mm size flat round punch to get tablet ma-
chine (Erweka AR 4100, Germany). The compositions of 
experimental factorial design are shown in Table 1.
32 Full factorial design
Response surface methodology (RSM) was characteristi-
cally employed to relate a response variable to the levels 
of the input variables and to generate a design matrix 
to choose the optimal formulations. A statistical model, 
which consisted of interactive and polynomial terms, was 
utilized to evaluate the responses (11,12). The responses 
were analyzed using analysis of variance (ANOVA) and 
the individual response parameters were evaluated using 
F test and polynomial equation was generated for each re-
sponse using multiple linear regression analysis.
Y = b0 + b1X1 + b2X2 + b12X1X2 + b11X12 + b22X22
Where, Y is the dependent variable, b0 is the arithmetic 
mean response of the nine runs and b1 is the estimated 
coefficient for the factor X1. The main effects (X1 and 
X2) represent the average result of changing one factor at 
a time from its low to high value. The interaction terms 
(X1 X2) show how the response changes when 2 factors 
are simultaneously changed. The polynomial terms (X12 
and X22) are included to investigate nonlinearity. A 32 full 
factorial design was employed to study the effect of inde-
pendent variables, ie, amount of Karaya gum (X1) and the 
amount of croscarmellose (X2) on dependent variables fri-
ability, disintegration time and Q5 (cumulative amount of 
drug release after 5 minutes).
After application of full factorial design and with the help 
of produced polynomial terms, amount of 2 formulation 
variable was optimized. The optimized amount of the 
croscarmellose and Karaya gum were incorporated in the 
tablet which was used as the check point of the regression 
analysis model (Tables 1 and 2).
Evaluation of mixed powder blend of drug and excipients
Evaluation of mixed blends of drug and excipients were 
carried out for all the formulations for angle of repose, 
bulk density, tapped density, Hausner ratio and Carr 
index.
Bulk density (Db) and tapped density (Dt)
Both bulk density and tapped bulk density were deter-
mined. A suitable amount of powder from each formu-
lation, previously lightly shaken to break agglomerates 
formed, was introduced into a 10 ml measuring cylinder. 
Table 1. Factorial design batches
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9
Ondansetron hydrochloride 4 4 4 4 4 4 4 4 4
Croscarmellose 3 6 9 3 6 9 3 6 9
Karaya gum 5 5 5 10 10 10 15 15 15
Aerosil 2 2 2 2 2 2 2 2 2
Magnesium stearate 1 1 1 1 1 1 1 1 1
Aspartame 1 1 1 1 1 1 1 1 1
Mannitol 20 20 20 20 20 20 20 20 20
Avicel PH 102 up to 150 150 150 150 150 150 150 150 150
Abbreviations: F, formulation.
Shahtalebi MA et al
Journal of HerbMed Pharmacology, Volume 4, Number 3, July 2015 http://www.herbmedpharmacol.com 104
After initial volume was observed, the cylinder was al-
lowed to fall under its own weight on to a hard surface 
from a height of 2.5 cm at 2 seconds intervals. The tapping 
was continued until no further change in volume was not-
ed. Bulk density and tapped bulk density were calculate 
using following formula (13):
=
   
   b
Weight of the power
Volume of the pac
D
king
=
   
    t
Weight of the power
Tapped volume of the pac
D
king
Carr index
The compressibility index of the powder blend was deter-
mined by Carr’s compressibility index. It is a simple test to 
evaluate the Db and Dt of a powder and the rate at which 
it packed down. The formula for Carr index is as below:
 100t b
t
D DCarr index
D
−
= ×
Where Dt is tapped density of the powder and Db is bulk 
density of the powder.
Hausner ratio
Hausner ratio was calculated from bulk and tapped den-
sity of ondansetron blend powder formulation and it is 
expressed as:
 t
b
DHausner ratio
D
=
Where Dt is tapped density and Db is bulk density.
Angle of repose
Angle of repose (θ) was determined using fixed funnel 
method. The height of the funnel was adjusted in such a 
way that the tip of the funnel just touched the apex of the 
heap of the granules. The granules were allowed to flow 
through the funnel freely onto the surface. The diameter 
of the granular cone was measured and angle of repose 
was calculated using the following equation:
tan h
r
θ =
Where h and r are the height and radius of the cone 
(Table 3).
Evaluation parameters of orally disintegrating tablets
Weight variation
Randomly, 20 tablets were selected after compression and 
the mean weight was determined (14). None of the tablets 
deviated from the average weight by more than ±7.5%.
Tablet thickness
The thickness was measured by placing tablet between 
two arms of the vernier calipers. Five tablets were taken 
and their thickness was measured (15).
Tablet hardness
Hardness of tablet is defined as the force applied across 
Table 2. Design and summary response data
Run
Independent variable in code form Dependent variable
Coded form Actual form
Factor A Factor B Karaya gum (mg) C.C (mg) F % DT (s) Q5 %
1 -1 -1 5 3 0.54 50 93
2 -1 0 5 6 0.50 48 96
3 -1 1 5 9 0.47 42 102
4 0 -1 10 3 0.45 39 101
5 0 0 10 6 0.41 35 100
6 0 1 10 9 0.37 31 98
7 1 -1 15 3 0.34 28 99
8 1 0 15 6 0.33 24 98
9 1 1 15 9 0.35 27 92
Abbreviations: C.C: croscarmellose; F, Friability; DT, Disintegration time; Q5, Drug release after 5 minutes.
Table 3. Powder flow properties of the ondansetron formulations
Code Angle of repose (θ) Bulk density (gr/cm3) Tapped density (gr/cm3) Carr index (I) Hausner ratio
F1 27.06 ± 0.02 0.58 ± 0.06 0.66 ± 0.07 12.12 ± 1.13 1.11
F2 27.09 ± 0.03 0.57 ± 0.09 0.66±0.08 13.63 ± 1.01 1.10
F3 26.57 ± 0.02 0.56 ± 0.05 0.65 ± 0.04 13.84 ± 0.35 1.08
F4 24.62 ± 0.03 0.58 ± 0.05 0.66 ± 0.07 12.12 ± 1.27 1.07
F5 24.42 ± 0.01 0.60 ± 0.03 0.69 ± 0.02 13.04 ± 1.05 1.10
F6 24.17 ± 0.05 0.61 ± 0.04 0.69 ± 0.06 11.59 ± 1.11 1,10
F7 24.51 ± 0.02 0.62 ± 0.04 0.67 ± 0.04 7.46 ± 1.36 1.07
F8 24.49 ± 0.01 0.58 ± 0.02 0.66 ± 0.08 12.12 ± 1.55 1.17
F9 24.45 ± 0.03 0.58 ± 0.04 0.66 ± 0.02 12.12 ± 0.35 1.08
Abbreviations: F, formulation.
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the diameter of the tablet in order to break the tablet. The 
hardness of the tablets was determined by diametral com-
pression using Erweka hardness tester (16).
Friability testing
This test was performed to determine the effects of friction 
and shock. Preweighed sample of 10 tablets was placed in 
the Erweka friabilator and rotated at 25 rpm for about 4 
minutes. The tablets were dedusted and reweighed, and 
the friability percentage was calculated. Compressed tab-
lets should not lose more than 1% of weight (17).
Percentage friabili   
 
ty 100Initial weight Final weight
Initial weight
×
−
=
Wetting time
The wetting time of the tablets was measured using a sim-
ple procedure. Five circular tissue papers of 10-cm diam-
eter were placed in a petridish with a 10-cm diameter. Ten 
milliliters of water containing eosin, a water-soluble dye, 
was added to the petridish. A tablet was carefully placed 
on the surface of tissue paper. The time required for water 
to reach the upper surface of the tablets was noted as the 
wetting time. The wetting times were measured (18).
Water absorption ratio
A piece of tissue paper folded twice was placed in a small 
petridish (internal diameter = 6.5 cm) containing 6 ml of 
water. A tablet was placed on the paper and the time re-
quired for complete wetting was then measured. The wa-
ter absorption ratio (R) was determined using the follow-
ing equation (19).
100a b
a
W WR
W
−
= ×
Where, Wb is the weight of the tablet before water ab-
sorption and Wa is the weight of the tablet after water ab-
sorption.
In vitro disintegration test
The in vitro disintegration studies were carried out using 
a digital tablet disintegration test apparatus (Erweka ZT, 
Germany). One tablet was placed in each of the 6 tubes 
of the basket assembly and then disk was added to each 
tube. This assembly was then suspended in a 1-liter beaker 
containing water with its temperature being maintained 
at 37 ± 2°C. The basket was then moved up and down 
through a distance of 5 to 6 cm, at the frequency of 28 
to 32 cycles per minute. The time required for complete 
disintegration of the tablet was recorded (20).
Dissolution test
The release rate of ondansetron hydrochloride from ODTs 
was determined using United State Pharmacopoeia (USP) 
XXIV dissolution testing apparatus II (paddle method). 
The dissolution test was performed using 500 ml of 0.1N 
HCl pH 1.2 as a dissolution medium, at 37 ± 0.5°C and 50 
rpm. A sample (5 ml) of the solution was withdrawn from 
the dissolution apparatus at 1, 2, 3, 4, 5, 10, 20 and 30 min-
utes. The samples were filtered through a 0.45 membrane 
filter. Absorbance of these solutions was measured at 310 
nm using a Shimadzu spectrophotometer. Cumulative 
percentage of drug release was calculated using an equa-
tion obtained from a standard curve (21).
Content uniformity
Ten tablets of each batch were weighed and powdered. Al-
iquot of this powder containing Ondansetron hydrochlo-
ride equivalent to 4 mg of Ondansetron was accurately 
weighed, suspended in approximately 50 ml of 0.1 N HCl 
and shaken for 15 minutes. Final volume was adjusted to 
100 ml with 0.1 N HCl and filtered (Whatman No.1 filter 
paper). From this 10 ml was diluted to 100 ml. The final 
volume was made by taking 2 ml of above solution and di-
luted to 10 ml with 0.1 N HCl. Absorbance of this solution 
was recorded at 310 nm using UV/Vis spectrophotometer 
against a reagent blank and the content was compared 
from a calibration curve prepared with standard ondan-
setron hydrochloride in the same medium (Table 4). The 
mean percentage drug content was calculated as an aver-
age of 3 determinations (22).
Data analysis
Response surface model factorial designs with 2 inde-
pendent formulation variables at 3 different levels were 
used to study the effect of dependent variables (23). All 
the batches of orally disintegration were statically (95% or 
P < .05) evaluated with regard to disintegration time, fri-
ability and drug release after 5 minutes.
Optimization of formulation ingredients
After generating the polynomial equations relating the de-
pendent and independent variables, the process was opti-
mized for responses, optimization was performed to ob-
tain the value of X1 and X2, which targeted disintegration 
time (DT) = 30 seconds; friability (F) = 0.35; drug release 
after 5 minutes (Q5) = 100. The optimized amount of cros-
carmellose and Karaya gum was incorporated in the tablet 
which was also used as the check point of the regression 
analysis model (24). The optimized ODT was prepared 
and evaluated for the physiochemical properties.
Results
Data analysis
A response surface model factorial design with 2 indepen-
dents variable at 3 different levels was used to study the 
effects in dependent variables. Transformed values of the 
batches along their results are shown in Table 5. The de-
pendent variables (DT, F, Q5) obtained at various levels of 
the 2 independent variables (X1 and X2) were subjected to 
multiple regressions to yield a second-order polynomial 
equation, the obtained coefficient are shown in Table 5. 
The DT, F and Q5 values measured form different batches 
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showed wide variations. These results clearly indicated 
that the DT, F and Q5 were strongly affected by the vari-
ables selected for the study. This was also reflected by the 
wide range of value for coefficients of the term equation. 
The value of correlation coefficient (R2) of polynomial re-
gression equation was found to be greater than 0.99, indi-
cating good fit for all dependent variables (Table 5).
X1 and X2 represent the average result if changing one 
variable at a time from its low level to its high level. The 
interaction terms (X1X2, X1X1 and X2X2) show how the DT, 
F and Q5 changes when 2 variables are simultaneously 
changed. Using the polynomial equations, the optimized 
formulations were obtained for the response parameters.
Polynomial equation for disintegration time
Y=34.67-2.83X1-10.17X2+1.75X1 X2+0.5X12+1.5X22
Polynomial equation for friability
Y=0.41-0.023X1-0.082 X2+0.02X1 X2+(6.667E-0.003)
X12+0.012X22
Table 4. Evaluation of the prepared orodispersible tablets of ondansetron
Tests F1 F2 F3 F4 F5 F6 F7 F8 F9
Weight variation
(Mean±SD)
5.7±0.51 6.0±0.22 5.5±0.34 5.0±0.28 5.4±0.30 5.0±0.54 5.2±0.28 5.0±0.39 5.4±0.41
Hardness (kg/cm2) 3.2±0.39 3.2±0.67 3.0±0.46 3.0±.0.69 3.0±0.59 3.3±0.34 3.1±0.76 3.3±0.94 3.2±0.32
Friability 0.57±0.16 0.68±0.14 0.81±0.15 0.93±0.147 0.96±0.157 0.72±0.155 0.44±0.138 0.80±0.149 0.66±0.153
Thickness (mm) 3.45 3.49 3.42 3.53 4.13 3.53 3.54 3.42 3.46
Wetting time (s) 32 29 26 25 23 18 16 19 21
Water absorption ratio 79.22 81.34 84.43 87.11 89.56 91.57 92.76 93.76 91.25
In vitro disintegration
time (s)
50 48 42 39 35 31 28 24 27
Assay 97.4 98.2 97.7 96.8 97.3 98.6 99.5 97.3 98.1
Abbreviations: F, formulation.
Table 5. Analysis of variance (ANOVA) response surface cubic model
Source Sum of squares Df Mean square F value Prob of P value< F value R2
For Fraibility
Model 0.045 5 9.049E-003 29.80 0.0093 0.9803
X
1
3.267E-003 1 3.267E-003 10.76 0.0207
X2 0.04 1 0.040 131.76 0.0747
X1X2 1.600E-003 1 1.600E-003 5.27 0.2048
X 2
8.889E-005 1 8.889E-005 0.29 0.2445
1
X 2 2.722E-004 1 2.722E-004 0.90 0.1755
2
Residual 9.111E-004 3 3.037E-004
Cor total 0.046 8
For Disintegration
time
Model 685.58 5 137.12 28.53 0.0098 0.9794
X
1
48.17 1 48.17 10.02 0.0506
X2 620.17 1 620.17 129.05 0.0015
X1X2 12.25 1 12.25 2.55 0.2086
X 2 0.50 1 0.50 0.10 0.7682
1
X 2 4.50 1 4.50 0.94 0.4046
2
Residual 14.42 3 4.81
Cor total 700.00 8
For Drug release
after 5 minutes
Model 274.69 5 54.94 9.06 0.0497 0.9379
X1 8.17 1 8.17 1.35 0.3298
X2 1.50 1 1.50 0.25 0.6531
X1X2 210.25 1 210.25 34.67 0.0098
X 2 20.06 1 20.06 3.31 0.1666
1
X 2 34.72 1 34.72 5.73 0.0965
2
Residual 18.19 3 6.06
Cor total 292.89 8
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Polynomial equation for drug release after 5 minutes
Y=100.78+1.17X1-0.5X2-7.25X1 X2-3.17X12-4.17 X22
Response surface counterplot
The relationship between the dependent and independent 
variable was further elucidated by constructing counter 
plots. The effects of X1 and X2 with their interaction on 
DT, F and Q5 at different levels (low, medium and high 
level) are displayed in Figures 1-3 .the interaction effect 
between X1 and X2 are shown in response surface plot 
Figures 4-6.
Optimization of orally disintegrating tablet
The optimization of the ODT was decided to target DT= 
30 seconds, F= 0.35% and drug release Q5= 100%.
Optimized concentrations obtained from the software 
and the counter plot are shown in Figure 7. Comparative 
values of predicted and observed responses along with the 
formulation components are reported in Table 6.
Discussion
An optimized formulation of Ondansetron ODT was 
prepared in this study using the “Direct compression” 
method. Formulation and optimization procedures were 
facilitated using 32 full factorial designs.
About the DT test, it was observed that with increasing 
croscarmellose and Karaya gum, DT was decreased; how-
ever, changes in the quantities of Karaya gum had more 
significant effect than croscarmellose (10,25).
On the other hand with increasing the percentage of Kara-
ya gum, speed of drug release was decreased, hence to cre-
ate a suitable response, an optimum limit in usage Karaya 
gum was found to have a proper amount of drug release.
Effect of formulation variable on friability
Value of prob>f less than 0.05 shows that the model for 
F is significant and Factor X2 is found to be significant in 
this case. The positive coefficient for X1 and X2 indicates 
favorable effect on F (increasing the amount of C.C and K 
[Karaya gum] decreases the F). The results convey us that 
factor X2 has significant effect on F than that of X1.
Effect of formulation variable on disintegration time
Value of prob>f less than 0.05 shows the model terms are 
significant and Factor X2 is found to be significant in this 
case The negative coefficient for X1 and X2 indicates fa-
vorable effect on disintegration time (DT) (increasing 
the amount of croscarmellose [C.C] and Karaya gum de-
creases the DT). The results convey us that factor X2 has 
significant effect on DT than that of X1.
Effect of formulation variable on Q5
Value of prob>f less than 0.05 shows the model for Q5 is 
significant, and X1X2 is significant. The positive coefficient 
for X1 and X2 indicates favorable effect on Q5 (increasing 
the amount of C.C and Karaya gum increases the Q5). The 
Figure 1. Counter plot for friability. F: friability, X1=A: Karaya gum, 
X2=B:C.C, C.C: croscarmellose.
Figure 2. Counter plot for disintegration time. X1=A: K, X2=B:C.C, 
C.C: croscarmellose, DT: disintegration time.
Figure 3. Counter plot for Q5. X1=A: K, X2=B:C.C, C.C: 
croscarmellose, Q5: drug release after 5 minutes.
Figure 4. Response surface plot for friability. F: friability, X1=A: 
Karaya gum, X2=B:C.C, C.C: croscarmellose.
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results convey us that factor X1 has significant effect on Q5 
than that of X2.
Conclusion
Overall, the results convey us that optimized ODTs of 
Ondansetron containing 7.78 mg of C.C and 7.88 mg of 
Karaya gum as a superdisintegrant by direct compression 
method showed responses as we desired.
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